Myelofibrosis
A PHASE 1/3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SELINEXOR, A SELECTIVE INHIBITOR OF NUCLEAR EXPORT, IN COMBINATION WITH RUXOLITINIB IN TREATMENT-NAIVE PATIENTS WITH MYELOFIBROSIS (XPORT-MF-034)
- Details
ClinicalTrials.gov ID:
NCT04562389
Diagnosis Type:
NA
USOR Number:
- Address
,
P: